U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 22:24:22 GMT 2025
Edited
by admin
on Mon Mar 31 22:24:22 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
N15SW1DIV8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BIMAGRUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
bimagrumab [INN]
Preferred Name English
Bimagrumab [WHO-DD]
Common Name English
O81T794R34
Common Name English
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS ACVR2B (ACTIVIN A RECEPTOR TYPE IIB, ACTR-IIB)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
BYM-338
Code English
BIMAGRUMAB [USAN]
Common Name English
BYM338
Code English
BIMAGRUMAB [JAN]
Common Name English
HUMAN ANTI-ACTRIIB MONOCLONAL ANTIBODY
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
EU-Orphan Drug EU/3/16/1779
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
FDA ORPHAN DRUG 369012
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
Code System Code Type Description
SMS_ID
100000164073
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
WIKIPEDIA
Bimagrumab
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
USAN
BC-30
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
LEGACY_FDA_UNII
O81T794R34
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
NCI_THESAURUS
C116852
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
ChEMBL
CHEMBL3137353
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
INN
9711
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
CAS
1356922-05-8
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
FDA UNII
N15SW1DIV8
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
EVMPD
SUB178426
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
DRUG BANK
DB12584
Created by admin on Mon Mar 31 22:24:22 GMT 2025 , Edited by admin on Mon Mar 31 22:24:22 GMT 2025
PRIMARY
From To
1_22 1_96
1_142 1_198
1_259 1_319
1_365 1_423
2_22 2_96
2_142 2_198
2_259 2_319
2_365 2_423
3_22 3_90
3_139 3_198
4_22 4_90
4_139 4_198
1_218 3_216
2_218 4_216
1_224 2_224
1_227 2_227
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_295
N 2_295
Related Record Type Details
ACTIVIN RECEPTOR TYPE-2B
TARGET -> INHIBITOR
Related Record Type Details
BIMAGRUMAB
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
N-TERMINAL MODIFICATION [3_1] [4_1] GLUTAMINE PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966